N4Pharma’s CEO nominated as one of the top 100 influential people in bio/pharma industry
The Medicine Maker, a leading medical journal have asked readers to nominate who they feel are the most influential people in the bio/pharmaceutical industry and N4 Pharma’s CEO, Nigel Theobald has been selected as one of the Top 100.
Delighted about the nomination, Nigel said “As a serial entrepreneur and passionate developer of new products, to now be in a position to own my own drug reformulation company with an incredibly experienced and respected board and two world class technology platforms, shows what can be achieved if you stick to a focused business model”.
N4 Pharma is a drug reformulation company that owns and exploits powerful new techniques which can deliver quick acting versions of established drugs. They are currently seeking £2,000,000 for 20% equity, click here to find out more.